Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A framework for cost-sharing policy analysis.

R J Rubin1, D N Mendelson

  • 1Lewin-VHI, Inc., Fairfax, Virginia, USA.

Pharmacoeconomics
|December 9, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure.

Journal of human hypertension·2011
Same author

Disease management and ESRD: where does it stand in Washington?

Nephrology news & issues·2002
Same author

The Patients' Bill of Rights and Medicare prescription drug benefits.

The Journal of medical practice management : MPM·2001
Same author

Disease management: what have we learned so far?

Blood purification·2001
Same author

The first 100 days.

The Journal of medical practice management : MPM·2001
Same author

Last year in brief and major issues of the new millennium.

The Journal of medical practice management : MPM·2000
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

Cost sharing in healthcare can increase patient cost awareness but requires careful design to avoid negative impacts. Policymakers can use these findings to create better healthcare benefit programs.

Area of Science:

  • Health Economics
  • Healthcare Policy
  • Public Health

Background:

  • Cost sharing is a common feature of healthcare systems.
  • Understanding its effects is crucial for effective healthcare policy.
  • Existing programs often face challenges like regressivity.

Purpose of the Study:

  • To evaluate the impact of healthcare cost-sharing programs.
  • To develop a framework for assessing these programs.
  • To synthesize international research on the topic.

Main Methods:

  • Developed a framework for describing and evaluating cost-sharing programs.
  • Conducted a comprehensive international literature search.
  • Analyzed findings from existing studies on cost sharing.

Related Experiment Videos

Main Results:

  • Cost sharing can enhance consumer attention to healthcare expenses.
  • Potential advantages exist, but program design is critical.
  • Regressivity and other issues are common in current cost-sharing models.

Conclusions:

  • Properly designed cost-sharing programs can offer benefits.
  • Policymakers need to anticipate effects and mitigate risks.
  • Innovative benefit designs can align with health system goals.